Fecal Microbiota Transplantation as an Adjunctive Therapy for Schizophrenia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Protocol
This paper outlines the protocol for a multicenter, randomized, double-blind, placebo-controlled trial in China designed to evaluate the efficacy and safety of fecal microbiota transplantation as an adjunctive therapy for improving symptoms and cognitive function in patients with non-treatment-resistant schizophrenia.